Vaginal ultrasound obsolete? Fibroblast growth factor 21 as a new diagnostic tool in missed abortion

Reflections

Like Comment
Related Content

VOLUME 116, ISSUE 4, P1050-1051

Authors:

Kilian Vomstein, M.D., Elisabeth Reiser, M.D., Bettina Toth, M.D.

Abstract:

Reflections on "Circulating fibroblast growth factor 21 as a potential biomarker for missed abortion in humans" by Yang et al.

Read the full text here. 

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders.